AJ Van Oosterhout, CL Hofstra, R Shields, B Chan, I Van Ark, PM Jardieu and FP Nijkamp
Department of Pharmacology and Pathophysiology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. A.J.M.VanOosterhout@far.ruu.nl

Antigen-specific T-cell activation requires the engagement of the T- cell receptor (TCR) with antigen as well as the engagement of appropriate costimulatory molecules. One of the most important pathways of costimulation is the interaction of CD28 on the T cell with B7-1/B7- 2 on antigen-presenting cells. In the present study, we have examined the in vivo effects of blocking the CD28:B7 T-cell costimulatory pathway by administration of mCTLA4-IgG in a murine model of allergic asthma. Mice were sensitized with ovalbumin and exposed to repeated ovalbumin inhalation challenges. In mice treated with a control antibody at the time of ovalbumin challenge a significant increase in the number of eosinophils (12.8 +/- 4.3 x 10(3) cells, P < 0.05) in the bronchoalveolar lavage (BAL) fluid and airway hyperresponsiveness to methacholine (49 +/- 15%, P < 0.05) was observed. In addition, serum levels of ovalbumin-specific IgE were significantly (P < 0.01) increased after ovalbumin challenge compared with saline challenge (1,133 +/- 261 experimental units [EU]/ml and 220 +/- 63 EU/ml, respectively). In mice treated with mCTLA4-IgG at the time of ovalbumin challenge, the infiltration of eosinophils into BAL fluid and the development of airway hyperresponsiveness to methacholine were completely inhibited. The upregulation of ovalbumin-specific IgE levels in serum was attenuated by mCTLA4-IgG treatment. Furthermore, addition of mCTLA4-IgG to cultures of parabronchial lymph node cells from sensitized mice inhibited the ovalbumin-induced interleukin-4 production. These data indicate the therapeutic potential of blocking T- lymphocyte costimulation by CTLA4-IgG as a possible immunosuppressive treatment for patients with allergic asthma.

This article has been cited by other articles:

				H. Jin, Y. Kang, L. Zhao, C. Xiao, Y. Hu, R. She, Y. Yu, X. Du, G. Zhao, T. Ng, et al. Induction of Adaptive T Regulatory Cells That Suppress the Allergic Response by Coimmunization of DNA and Protein Vaccines J. Immunol., April 15, 2008; 180(8): 5360 - 5372. [Abstract] [Full Text] [PDF]

				K. C. Beier, T. Kallinich, and E. Hamelmann T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease Eur. Respir. J., August 1, 2007; 30(2): 383 - 390. [Abstract] [Full Text] [PDF]

				F. van Wijk, S. Nierkens, W. de Jong, E. J. M. Wehrens, L. Boon, P. van Kooten, L. M. J. Knippels, and R. Pieters The CD28/CTLA-4-B7 Signaling Pathway Is Involved in Both Allergic Sensitization and Tolerance Induction to Orally Administered Peanut Proteins J. Immunol., June 1, 2007; 178(11): 6894 - 6900. [Abstract] [Full Text] [PDF]

				S. Nierkens, M. Aalbers, M. Bol, R. Bleumink, P. van Kooten, L. Boon, and R. Pieters Differential Requirement for CD28/CTLA-4-CD80/CD86 Interactions in Drug-Induced Type 1 and Type 2 Immune Responses to Trinitrophenyl-Ovalbumin J. Immunol., September 15, 2005; 175(6): 3707 - 3714. [Abstract] [Full Text] [PDF]

				C. Mueller and A. August Attenuation of Immunological Symptoms of Allergic Asthma in Mice Lacking the Tyrosine Kinase ITK J. Immunol., May 15, 2003; 170(10): 5056 - 5063. [Abstract] [Full Text] [PDF]

				T. B. H. Geijtenbeek, P. C. Groot, M. A. Nolte, S. J. van Vliet, S. T. Gangaram-Panday, G. C. F. van Duijnhoven, G. Kraal, A. J. M. van Oosterhout, and Y. van Kooyk Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo Blood, September 26, 2002; 100(8): 2908 - 2916. [Abstract] [Full Text] [PDF]

				S. Y. Lee, Y. H. Lee, C. Shin, J. J. Shim, K. H. Kang, S. H. Yoo, and K. H. In Association of Asthma Severity and Bronchial Hyperresponsiveness With a Polymorphism in the Cytotoxic T-Lymphocyte Antigen-4 Gene* Chest, July 1, 2002; 122(1): 171 - 176. [Abstract] [Full Text] [PDF]

				D. T. Deurloo, B. C.A.M. van Esch, C. L. Hofstra, F. P. Nijkamp, and A. J.M. van Oosterhout CTLA4-IgG Reverses Asthma Manifestations in a Mild but Not in a More ""Severe"" Ongoing Murine Model Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 751 - 760. [Abstract] [Full Text] [PDF]

				B. U. Gajewska, F. K. Swirski, D. Alvarez, S. A. Ritz, S. Goncharova, M. Cundall, D. P. Snider, A. J. Coyle, J.-C. Gutierrez-Ramos, M. R. Stampfli, et al. Temporal-Spatial Analysis of the Immune Response in a Murine Model of Ovalbumin-Induced Airways Inflammation Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 326 - 334. [Abstract] [Full Text] [PDF]

				J. S. Burr, S. L. Kimzey, D. R. Randolph, and J. M. Green CD28 and CTLA4 Coordinately Regulate Airway Inflammatory Cell Recruitment and T-Helper Cell Differentiation after Inhaled Allergen Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 563 - 568. [Abstract] [Full Text]

				M. Mathur, K. Herrmann, Y. Qin, F. Gulmen, X. Li, R. Krimins, J. Weinstock, D. Elliott, J. A. Bluestone, and P. Padrid CD28 Interactions with Either CD80 or CD86 Are Sufficient to Induce Allergic Airway Inflammation in Mice Am. J. Respir. Cell Mol. Biol., October 1, 1999; 21(4): 498 - 509. [Abstract] [Full Text]

				C. E Donovan and P. W Finn Immune mechanisms of childhood asthma Thorax, October 1, 1999; 54(10): 938 - 946. [Full Text]

				S. E Burastero and G. A Rossi Immunomodulation by interference with co-stimulatory molecules: therapeutic perspectives in asthma Thorax, June 1, 1999; 54(6): 554 - 557. [Full Text]

				C. L. Hofstra, I. Van Ark, G. Hofman, F. P. Nijkamp, P. M. Jardieu, and A. J. M. Van Oosterhout Differential Effects of Endogenous and Exogenous Interferon-gamma on Immunoglobulin E, Cellular Infiltration, and Airway Responsiveness in a Murine Model of Allergic Asthma Am. J. Respir. Cell Mol. Biol., November 1, 1998; 19(5): 826 - 835. [Abstract] [Full Text]